Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-25-000006

Chief Discovery Officer acquired 35,953 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kreitzer Anatol · Chief Discovery Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-27 Grant or award : show line 1 in the form +35,953 35,953 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-27 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +146,052 146,052 D
Loading xslF345X05/form4-10282025_041012.xml…